New Structures in Neurology: Palliative Care for Neurological Patients

Abstract

Although patients with incurable neurological diseases suffer from a variety of distressing symptoms and may die from their neurological condition and associated complications, palliative and hospice care for these patients to date remains rare. Initial estimates indicate that on average 10% of all patients suffering from a neurological disease need palliative and hospice care. However, within German neurology departments, only few physicians (on average 1.3/department) and nurses (on average 2.2./department) are specialized in palliative and hospice care and only about 3% of patients cared for in palliative or hospice care structures suffer from neurological diseases (in contrast to the approximately 80% of patients suffering from oncological diseases). This rather low number is due to the gradual increase in the awareness of palliative and hospice care needs for neurological patients and a currently predominant supply of oncological patients in palliative and hospice care structures that are primarily aimed at these patients. Correspondingly, the special aspects of neurological patients are currently not adequately addressed in the palliative training curricula of healthcare professionals. Rather, patients with advanced neurological conditions are medically cared for by general practitioners and by the existing inpatient and outpatient neurology structures, which may also offer sub-specialty services. Consequently, adequate care for severely affected neurological patients becomes difficult as soon as these patients are hardly able to visit these structures because home-based specialist treatment is currently rendered and financed only to a limited degree. Novel yet to date rare approaches, mostly of international origin, suggest that these patients may benefit from specialized home-based services, combining neurological and palliative care expertise. At present, data that characterizes the situation of neuro-palliative care in Germany remains scarce. In addition to the already known supply gaps (e. g., low rate of neurologists trained in palliative medicine as well as of nurses working in neurology trained in palliative care, lack of consideration of the specific (care) needs of neurological patients in general and specialized palliative and hospice care structures, few available home-based outpatient specialists) research is a prerequisite to identify current gaps in palliative care of neurological patients in more detail and how these might be overcome in the future.

Key words

palliative care - neurological diseases - healthcare structures

• References

• 1 Golla H, Ebke M, Rolke R. et al. Integration von Palliativ- und Hospizstrukturen in die Versorgung Neurologischer Patienten – Meinungsbild neurologischer Chefärzte in Deutschland. Fortschr Neurol Psychiatr 2016; 84: 733-738
• 2 World Health Organisation (WHO). Definition of palliative care. Im Internet: http://www.who.int ; (Abrufdatum: 28.07.2016)
• 3 Hospiz- und Palliativerfassung (HOPE). HOPE-Bericht 2015. Im Internet: https://www.hope-clara.de (Abrufdatum: 28.07.2016)
• 4 Statistisches Bundesamt. Die 10 häufigsten Todesursachen insgesamt – Sterbefälle nach der ICD 10 im Jahr 2014. Im Internet: https://www.destatis.de (Abrufdatum: 23.09.2016)
• 5 Scalfari A, Knappertz V, Cutter G. et al. Mortality in patients with multiple sclerosis. Neurology 2013; 81: 184-192
• 6 Macleod AD, Taylor KS, Counsell CE. Mortality in Parkinson's disease: A systematic review and meta-analysis. Mov Disord 2014; 29: 1615-1622
• 7 Wolf J, Safer A, Wöhrle JC. et al. Factors predicting one-year mortality in amyotrophic lateral sclerosis patients – data from a population-based registry. BMC Neurol 2014; 14: 197
• 8 Higginson IJ, Hart S, Silber E. et al. Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliat Care 2006; 22: 158-165
• 9 Golla H, Galushko M, Pfaff H. et al. Unmet needs of severely affected multiple sclerosis patients: The health professionals' view. Palliat Med 2012; 26: 139-151
• 10 Basedow-Rajwich B, Koehler J. Besonderheiten der neuropalliativmedizinischen Versorgung schwerst betroffener MS-Patienten. Akt Neurol 2015; 42: 11-15
• 11 Lorenzl S, Nubling G, Perrar KM. et al. Palliative treatment of chronic neurologic disorders. Handb Clin Neurol 2013; 118: 133-139
• 12 Hensler M, Paul S, Abright C. et al. Progressive supranuclear palsy: Living environment of the patients in Germany. Nervenarzt 2011; 82: 207-214
• 13 Lorenzl S. Multimorbidity of neurological patients in palliative care units. Nervenarzt 2014; 85: 409-416
• 14 Grehl T. Diagnostics and therapy for amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr 2013; 81: 592-603
• 15 Oliver DJ, Campbell C, O'brien T. et al. Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010; 11: 562-564
• 16 Ostgathe C, Alt-Epping B, Golla H. et al. Non-cancer patients in specialized palliative care in Germany: What are the problems?. Palliat Med 2011; 25: 148-152
• 17 Golla H, Ale Ahmad M, Galushko M. et al. Glioblastoma multiforme from diagnosis to death: A prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs. Support Care Cancer 2014; 22: 3341-3352
• 18 Oberndorfer S, Lindeck-Pozza E, Lahrmann H. et al. The end-of-life hospital setting in patients with glioblastoma. J Palliat Med. 2008; 11: 26-30
• 19 Thier K, Calabek B, Tinchon A. et al. The last 10 days of patients with glioblastoma: Assessment of clinical signs and symptoms as well as treatment. Am J Hosp Palliat Care 2016; 33: 985-988
• 25 Ostgathe C, Gaertner J, Kotterba M. et al. Hospice and palliative Care Evaluation (HOPE) Working Group in Germany. Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer 2010; 18: 1157-1163
• 20 Golla H, Galushko M, Pfaff H. et al. Multiple sclerosis and palliative care – Perceptions of severely affected multiple sclerosis patients and their health professionals: A qualitative study. BMC Palliat Care 2014; 13: 1
• 21 McIlfatrick S. Assessing palliative care needs: Views of patients, informal carers and healthcare professionals. J Adv Nurs 2007; 57: 77-86
• 22 Kierner KA, Gartner V, Bartsch R. et al. Attitudes towards palliative care in primary metastatic cancer: A survey among oncologists. Wien Klin Wochenschr 2010; 122: 45-49
• 23 Kümpfel T, Hoffmann LA, Pöllmann W. et al. Palliative care in patients with severe multiple sclerosis: Two case reports and a survey among German MS neurologists. Palliat Med 2007; 21: 109-114
• 24 Voltz R. Palliative care for multiple sclerosis: A counter-intuitive approach?. Mult Scler 2010; 16: 515-517
• 26 Stolberg M. Die Geschichte der Palliativmedizin. Medizinische Sterbebegleitung von 1500 bis heute. Frankfurt a. M.: Mabuse Verlag; 2011
• 27 Oliver D, Silber E. End of life care in neurological disease. In: Oliver D. (ed.) End of life care in neurological disease. London: Springer; 2012
• 28 Ärztinnen nach Bezeichnungen und Tätigkeitsarten, Tabelle 4, Blatt 5. Im Internet: http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/Statistik2015/Stat15AbbTab.pdf (Abrufdatum: 03.10.2016)
• 29 Knies AK, Golla H, Strupp J. et al. A palliative care hotline for multiple sclerosis: A pilot feasibility study. Palliat Support Care 2015; 13: 1071-1078
• 30 Funke A, Grehl T, Großkreutz J. et al. Provision of assistive devices in amyotrophic lateral sclerosis. Analysis of 3 years case management in an internet-based supply network. Nervenarzt 2015; 86: 1007-1017
• 31 Temel JS, Greer JA, Muzikansky A. et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742
• 32 Bakitas MA, Tosteson TD, Li Z. et al. Early versus delayed initiation of concurrent palliative oncology care: Patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 2015; 33: 1438-1445
• 33 Zimmermann C, Swami N, Krzyzanowska M. et al. Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial. Lancet 2014; 383: 1721-1730
• 34 Gaertner J, Wolf J, Hallek M. et al. Standardizing integration of palliative care into comprehensive cancer therapy – a disease specific approach. Support Care Cancer 2011; 19: 1037-1043
• 35 Leray E, Yaouang J, Le Page E. et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain 2010; 133 (Pt7) 1900-1913
• 36 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF), Deutschen Krebsgesellschaft e.V. (DKG), Deutsche Krebshilfe. Leitlinien-Programm für Onkologie: S3-Leitlinie - Palliativmedizin für Patienten mit einer nicht heilbaren Krankheit. Im Internet: http://www.awmf.org (Abrufdatum: 02.10.2016)
• 37 Richtlinie des gemeinsamen Bundesausschusses zur Verordnung von spezialisierter ambulanter Palliativversorgung. Im Internet: https://www.g-ba.de/downloads/62-492-437/SAPV-RL_2010-04-15.pdf (Abrufdatum: 05.10.2016)
• 38 Empfehlungen des GKV Spitzenverbandes nach §132d Abs. 2 SGB V für die spezialisierte ambulante Palliativversorgung. Im Internet: https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1/hospiz_palliativversorgung/Palliativ_Empfehlungen_nach__132d_Abs_2_SGB_V_05-11-20102.pdf (Abrufdatum: 05.10.2016)
• 39 Gesetz zur Verbesserung der Hospiz- und Palliativversorgung in Deutschland (Hospiz- und Palliativgesetz - HPG). Im Internet: http://www.bgbl.de/xaver/bgbl/start.xav?startbk = Bundesanzeiger_BGBl#__bgbl__ %2F %2F * [ %40attr_id %3D %27bgbl115s2114.pdf %27]__1455177642383 (Abrufdatum: 05.10.2016)
• 40 Rahmenvereinbarung nach § 39a Abs. 2 Satz 8 SGB V zu den Voraussetzungen der Förderung sowie zu Inhalt, Qualität und Umfang der ambulanten Hospizarbeit. Im Internet: https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1/hospiz_palliativversorgung/Rahmenvereinbarung__39a_Abs_2_Satz_8_SGB_V_ambulante_Hospizarbeit.pdf (Abrufdatum: 05.10.2016)
• 41 Barnes MP. Principles of neurological rehabilitation. J Neurol Neurosurg Psychiatry 2003; 74 (Suppl. 04) iv3-iv7
• 42 Department of Health (DH). The National Service Framework for Long-term Conditions (14.08.2016). Im Internet: https://www.gov.uk Stand: 14.08.2016
• 43 Turner-Stokes L, Sykes N, Silber E. Guideline Development Group. Long-term neurological conditions: Management at the interface between neurology, rehabilitation and palliative care. Clin Med 2008; 8: 186-191
• 44 Jackson D, McCrone P, Turner-Stokes L. Costs of caring for adults with long-term neurological conditions. J Rehabil Med 2013; 45: 653-661
• 45 Turner-Stokes L, Sykes N, Silber E. et al. From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care in managing people with long-term neurological conditions. Clin Med 2007; 7: 129-136
• 46 Wade DT, de Jong BA. Recent advances in rehabilitation. Br Med J 2000; 320: 1385-1388
• 47 Tookman AJ, Hopkins K, Scharpen-von-Heussen K. Rehabilitation in palliative medicine. In: Doyle D, Hanks G, Cherney N, Calman K. (eds.). Oxford Textbook of Palliative Medicine. 3rd ed. Oxford: Oxford University Press; 2004
• 48 The National Council for Palliative Care. End of life care in long term neurological conditions: A framework for implementation (14.08.2016). Im Internet: https://www.mssociety.org.uk Stand: 14.08.2016
• 49 Hussain J, Adams D, Campbell C. End-of-life care in neurodegenerative conditions: Outcomes of a specialist palliative neurology service. Int J Palliat Nurs 2013; 19: 162-169
• 50 Higginson IJ, Hart S, Burman R. et al. Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up. BMC Palliat Care 2008; 7: 7
• 51 Higginson IJ, McCrone P, Hart SR. et al. Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manag 2009; 38: 816-826
• 52 Edmonds P, Hart S, Wei G. et al. Palliative care for people severely affected by multiple sclerosis: Evaluation of a novel palliative care service. Mult Scler 2010; 16: 627-636
• 53 Veronese S, Gallo G, Valle A et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Support Palliat Care 2015; 16:
• 54 Pace A, Di Lorenzo C, Capon A. et al. Quality of care and rehospitalization rate in the last stage of disease in brain tumor patients assisted at home: a cost effectiveness study. J Palliat Med 2012; 15: 225-227
• 55 Strupp J, Romotzky V, Galushko M. et al. Palliative care for severely affected patients with multiple sclerosis: When and why? Results of a Delphi survey of health care professionals. J Palliat Med 2014; 17: 1128-1136
• 56 Radbruch L, Nauck F, Ostgathe C. et al. What are the problems in palliative care? Results from a representative survey. Support Care Cancer 2003; 11: 442-451
• 57 Stiel S, Pollok A, Elsner F. et al. Validation of the symptom and problem checklist of the German Hospice and Palliative Care Evaluation (HOPE). J Pain Symptom Manage 2012; 43: 593-605
• 58 Wilson E, Seymour J, Aubeeluck A. Perspectives of staff providing care at the end of life for people with progressive long-term neurological conditions. Palliat Support Care 2011; 9: 377-385
• 59 Pang WF, Kwan BC, Chow KM. et al. Predicting 12-month mortality for peritoneal dialysis patients using the "surprise" question. Perit Dial Int 2013; 33: 60-66
• 60 Moroni M, Zocchi D, Bolognesi D. et al. The 'surprise' question in advanced cancer patients: A prospective study among general practitioners. Palliat Med 2014; 28: 959-964
• 61 Wynia K, Annema C, Nissen H. et al. Design of a Randomised Controlled Trial (RCT) on the effectiveness of a Dutch patient advocacy case management intervention among severely disabled Multiple Sclerosis patients. BMC. Health Serv Res 2003; 10: 142
• 62 Young L, Healey K, Charlton M. et al. A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol. F1000Res 2015; 18: 872
• 63 Champagne M, Mongeau S. Effects of respite care services in a children’s hospice: The parents’ point of view. J Palliat Care 2012; 28: 245-251
• 64 Rahmenvereinbarung nach § 39a über Art und Umfang sowie Sicherung der Qualität der stationären Hospizversorgung vom 30.03.1998, i.d. F. vom 14.04.2014. Im Internet: http://www.dhpv.de/tl_files/public/Service/Gesetze %20und %20Verordnungen/2009-07-23_RV-stationaer.pdf (Abrufdatum 10.02.2017)